Inventor · Yeadon, PA, US

Katherine A. High

29Patents
9h-index
34Co-inventors
75Inventor score

Filing activity: Mar 12, 1998 → Oct 28, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US6093392A Methods and compositions for use in gene therapy for treatment of hemophilia Chemistry; Metallurgy 40 Expired
US9255250B2 Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene Human Necessities 39 Active
US8071293B2 PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis Physics 27 Active
US7220849B2 Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factor Chemistry; Metallurgy 21 Expired
US9408904B2 Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy Chemistry; Metallurgy 18 Active
US9840719B2 Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissues Chemistry; Metallurgy 16 Active
US9909142B2 Composition and methods for highly efficient gene transfer using AAV capsid variants Chemistry; Metallurgy 14 Active
US7998734B2 Methods and compositions for use in gene therapy for treatment of hemophilia Chemistry; Metallurgy 12 Active
US10392632B2 AAV8 vector with enhanced functional activity and methods of use thereof Chemistry; Metallurgy 10 Active
US9629930B2 Methods and compositions for treating hemophilia B Human Necessities 8 Active
US9175280B2 Methods and compositions for treating hemophilia B Human Necessities 8 Active
US10799566B2 Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues Chemistry; Metallurgy 5 Active
US11110153B2 Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues Chemistry; Metallurgy 3 Active
US8063022B1 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy Human Necessities 1 Expired
US11491213B2 Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues Chemistry; Metallurgy 1 Active
US7211558B2 Compositions and methods for the treatment of hemophilia A Human Necessities 1 Expired
US10537617B2 Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues General 0 Revoked
US11559589B2 Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy Physics 0 Active
US11878056B2 Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy Chemistry; Metallurgy 0 Active
US9075044B2 Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy Physics 0 Active
US10448823B2 Apparatus and methods for testing visual function and functional vision at varying luminance levels Human Necessities 0 Active
US11014975B2 Expression cassette for packaging and expression of variant factor VIII for the treatment of hemostasis disorders Chemistry; Metallurgy 0 Active
US10328145B2 Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy Chemistry; Metallurgy 0 Active
US11408899B2 AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies Physics 0 Active
US11279950B2 Composition and methods for highly efficient gene transfer using AAV capsid variants Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.